Stock & Company Details
Alkermes plc $ALKS
Price:
N/A
N/A
168M
$6.7B
52 Week High:
N/A
10 Day Average Volume:
N/A
104.21
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ALKS technical indicators
Latest Alkermes plc (ALKS) indicator readings as of 2026-10-08.
ALKS's 14-day RSI is 33.1, in neutral territory. ADX reads 31.2, indicating a trending market. MACD (12, 26, 9) is -1.60, below the zero line.
ALKS backtested strategy results
How 4 rule-based strategies performed on Alkermes plc (ALKS) over recent history, last backtested 2026-10-07. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | +120.4% | 64% | 11 | -16.6% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | +61.9% | 39% | 28 | -33.6% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | +16.6% | 41% | 32 | -48.5% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | +48.4% | 67% | 21 | -20.2% |
Overview
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.
Finance Bot
Ask your questions
Start by typing a question below.
